ArticleQuantitative imaging in medicine and surgery2026
Deep learning-based computed tomography detection of early lymph node metastasis in head and neck cancer.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cervical lymph node metastasis (LNM) significantly influences the prognosis of patients with head and neck squamous cell carcinoma (HNSCC). However, conventional computed tomography (CT) diagnostics are susceptible to high false-negative rates for small lesions, exhibit considerable inter-reader variability, and are labor-intensive due to the requirement for manual evaluation by radiologists. This study aimed to develop and validate a deep learning-based model incorporating an attention mechanism, termed the deep learning-based cervical lymph node metastasis detection model (DL-CervLNM), to automatically detect LNM in contrast-enhanced CT scans. This model was designed to address challenges related to the detection of small lesions, inter-observer variability, and diagnostic efficiency. Methods: A total of 6,860 contrast-enhanced CT scans from 481 patients with HNSCC at Fujian Cancer Hospital between 2020 and 2024 were retrospectively collected and analyzed for model development. An asymmetric context-aware cascade detection (ACCD) framework was introduced, consisting of two principal modules: (I) an attention-enhanced You Only Look Once version 8 (YOLOv8) stage, specifically designed to generate candidate regions with high recall rates; and (II) a region-based refinement stage that incorporates the Faster region-based convolutional neural network (R-CNN) algorithm to enable context-aware suppression of false positives. The efficacy of the ACCD framework was rigorously assessed in comparison to board-certified radiologists and state-of-the-art baseline models. The primary evaluation metrics included the mean average precision (mAP) at an intersection-over-union (IoU) threshold of 0.5 (mAP@0.5), the area under the receiver operating characteristic curve (AUC), the F1-score, and computational efficiency metrics. Results: In the context of LNM detection using CT imaging, DL-CervLNM achieved a mAP@0.5 of 94.9% and an AUC of 0.980, outperforming both current state-of-the-art models and experienced radiologists. The model exhibited enhanced sensitivity (90.6%) and specificity (94.5%), with a notable proficiency in identifying small lesions, achieving an accuracy of 93.2% compared to 76.4% for radiologists. In addition, the system improved clinical workflow efficiency by enabling real-time processing at 38.5 frames per second (FPS), thereby significantly reducing interpretation and reporting times by 51.7% and 98.6%, respectively. Conclusions: DL-CervLNM exhibited enhanced accuracy and reliability in detecting cervical LNM on CT scans compared to current methodologies. This model has the potential to improve diagnostic efficiency and consistency, thereby aiding radiologists in the early identification of metastatic lymph nodes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.